Supplement Claims For Autism Treatment Could Ring A Bell At FTC
This article was originally published in The Tan Sheet
Executive Summary
The firm that challenged Pursuit of Research’s claims and prompted a NAD review, NourishLife LLC, already incurred FTC enforcement about unsubstantiated claims that products treat childhood speech disorders.
You may also be interested in...
Prevagen Study Data Withstand False Ad Complaint By FTC, New York AG
A federal judge dismissed a complaint filed by FTC and New York AG Schneiderman against Quincy Biosciences about claims for Prevagen cognitive supplement. The complaint did not show the company violated the FTC Act because it pointed only to possible errors in a supporting study.
New York AG And FTC Target Prevagen Memory Claims
FTC and New York Attorney General file a lawsuit dietary alleging supplement marketer Quincy Bioscience preyed on elderly consumers with a multi-channel ad campaign claims its supplement Prevagen boosted memory.
NAD Could Jog Cognitive Benefit Supplement Firm's Memory With FTC Call
NAD refers UltraMax Health's supplement claim to the FTC after it fails to provide substantiation. CRN emphasizes claims alone are not the problem, but the firm's failure to provide substantiation.